Gennex Laboratories Share Price

With reference to the captioned subject matter pursuant to Regulation 74(5) of SEBI (DP) Regulations 2018 we hereby submit the Certificate received from the M/s. R&D Infotech Private Limited Registrar and Transfer Agent of the Company for the quarter ended December 31 2025.We request you to take the above information on record and acknowledge receipt of the same.

Notice is hereby given that in pursuance of SEBI (PIT) Regulations 2015 and Companys code of conduct for Regulating Monitoring and Reporting of Trading by Insiders the Trading Window for dealing in the securities of the Company shall remain closed from January 01 2026 till 48 hours after the public announcement through Board of Directors in their meeting held for announcing the Un-audited Standalone and Consolidated Financial Results for the Third quarter and Nine months ended December 31 2025 along with other matters for which Trading Window is required to be closed.The Board Meeting Date to approve the Un-audited Standalone and Consolidated Financial Results of the Company for the Third Quarter and Nine months ended December 31 2025 will be informed in due course.All Promoters/Designated/Connected persons are advised not to trade in the securities of the Company directly or indirectly during the aforesaid period of Closure of Trading Window.

Pursuant to Regulation 47 of SEBI (LODR) Regulations 2015 please find enclosed herewith Newspaper Publication on Unaudited (Standalone and Consolidated) Financial Results for the Quarter and Half year ended September 30 2025 announced by the Board of Directors in its meeting held on Friday November 14 2025. Financial Results had been published in both Business Standard (English) and Saksham (Telugu - Local) on November 16/17 2025.We request you to take the above information on record and acknowledge receipt of the same.

In just concluded meeting of Board of Directors the Board approved and considered the following items:1. Unaudited (Standalone and Consolidated) Financial Statements for the quarter and half year ended September 30 2025;2. Limited Review Reports from the Statutory Auditors on Unaudited (Standalone and Consolidated) Financial Statements for the Quarter and Half year ended September 30 2025;3. Other BusinessWe hereby submit that the Board Meeting had commenced at 4.00 PM and concluded at 5.00 PM.This information is also being uploaded on the Company website: www.gennexlab.com.We request you to take the above information on record and acknowledge receipt of the same.

In just concluded Meeting of Board of Directors the Board Approved and considered the following items:1. Unaudited (Standalone and Consolidated) Financial Statements for the Quarter and Half year ended September 30 2025 (annexed herewith); 2. Limited review reports from the Statutory Auditor on Unaudited (Standalone and Consolidated) Financial Statements for the Quarter and Half year ended September 30 2025 (annexed here with);3. Other Business items. We hereby submit that the Board Meeting had commenced at 04:00 PM and concluded at 5:00 PM.This intimation is also uploaded on the Company website: www.gennexlab.com. We request you to take the above information on record and acknowledge the receipt of the same.